SCHEMBL5643755

SCHEMBL5643755

CCCCCC(C)(C)c1cc(-n2nc3ccc(-c4ccc(OC)cc4)cc3n2)c(O)c(C(C)(C)c2ccccc2)c1

nearest known ligand 0.38

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 9/20 0.38
CNR1 P21554 6/20 0.38
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
MGLL Q99685 5/20 0.32
KDR P35968 1/20 0.32
LTB4R Q15722 1/20 0.32
ADORA3 P0DMS8 1/20 0.32
ACSS2 Q9NR19 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5648044 0.94 CNR2 (0.36) CNR2CNR1NPC1RAB9A
SCHEMBL5647618 0.93 CNR2 (0.37) CNR2CNR1NPC1RAB9A
SCHEMBL5648165 0.93 CNR2 (0.37) CNR2CNR1NPC1RAB9A
SCHEMBL4822440 0.90 CNR2 (0.42) CNR2CNR1NPC1RAB9ALTB4R
SCHEMBL5646340 0.89 CNR2 (0.35) CNR2CNR1LTB4RADORA3
SCHEMBL5643752 0.88 KDR (0.34) NPC1RAB9AMGLLKDRACSS2
SCHEMBL5645946 0.87 CNR2 (0.39) CNR2CNR1ACSS2
SCHEMBL6613904 0.87 CNR2 (0.33) CNR2CNR1
SCHEMBL5646864 0.86 TLR8 (0.35) CNR2CNR1LTB4R
SCHEMBL5645118 0.86 CNR1 (0.33) CNR2CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7166659-B2 Substituted 5-aryl-2-(2-hydroxyphenyl)-2H-benzotriazole UV absorbers, compositions stabilized therewith and process for preparation thereof CIBA SPECIALTY CHEMICALS CORPORATION (US) 2007-01-23 US disclosed
US-7148274-B2 Substituted 5-aryl-2-(2-hydroxyphenyl)-2h-benzotriazole UV absorbers, compositions stabilized therewith and process for preparation thereof CIBA SPECIALTY CHEMICALS CORPORATION (US) 2006-12-12 US disclosed
EP-1337520-B1 SUBSTITUTED 5-ARYL AND 5-HETEROARYL-2-(2-HYDROXYPHENYL)-2H-BENZOTRIAZOLE DERIVATIVES AS UV ABSORBERS CIBA SC HOLDING AG (CH) 2004-12-15 EP disclosed
US-20040192927-A1 Substituted 5-aryl-2-(2-hydroxyphenyl)-2H-benzotriazole UV absorbers, compositions stabilized therewith and process for preparation thereof PASTOR STEPHEN D (US) 2004-09-30 US disclosed
US-20040157966-A1 Substituted 5-aryl-2-(2-hydroxyphenyl)-2h-benzotriazole UV absorbers, compositions stabilized therewith and process for preparation thereof PASTOR STEPHEN D (US) 2004-08-12 US disclosed
US-6774238-B2 REACTING 5-SUBSTITUTED BENZOTRIAZOLE WITH ARYLBORONIC ACID IN PRESENCE OF PALLADIUM CATALYST; DEHALOGENATION; ARYLATION CIBA SPECIALTY CHEMICALS CORPORATION 2004-08-10 US disclosed
US-20040092628-A1 Substituted 5-aryl-2-(2-hydroxyphenyl)-2h-benzotriazole UV absorbers, compositions stabilized therewith and process for preparatiion thereof PASTOR STEPHEN D (US) 2004-05-13 US disclosed
US-6703510-B2 MORE STABLE AND DURABLE; AUTOMOTIVE COATINGS, CANDLE WAX CIBA SPECIALTY CHEMICALS CORPORATION 2004-03-09 US disclosed
US-20030213164-A1 Substituted 5-aryl-2-(2-hydroxyphenyl)-2H-benzotriazole UV absorbers, compositions stabilized therewith and process for preparation thereof PASTOR STEPHEN D (US) 2003-11-20 US disclosed
US-6649770-B1 Exhibit superior hydrolytic stability, handling and storage stability as well as good resistance to extractability when present in stabilized composition CIBA SPECIALTY CHEMICALS CORPORATION 2003-11-18 US disclosed
EP-1337520-A1 SUBSTITUTED 5-ARYL AND 5-HETEROARYL-2-(2-HYDROXYPHENYL)-2H-BENZOTRIAZOLE DERIVATIVES AS UV ABSORBERS Ciba SC Holding AG (CH) 2003-08-27 EP disclosed
WO-2002042281-A1 SUBSTITUTED 5-ARYL AND 5-HETEROARYL-2-(2-HYDROXYPHENYL)-2H-BENZOTRIAZOLE DERIVATIVES AS UV ABSORBERS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2002-05-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040192927-A1 Substituted 5-aryl-2-(2-hydroxyphenyl)-2H-benzotriazole UV absorbers, compositions stabilized therewith and process for preparation thereof EBPL, DDT, AHR CNR2 1960/4885CNR1 2333/4885NPC1 4339/4885
US-20030213164-A1 Substituted 5-aryl-2-(2-hydroxyphenyl)-2H-benzotriazole UV absorbers, compositions stabilized therewith and process for preparation thereof EBPL, DDT, AHR CNR2 1960/4885CNR1 2333/4885NPC1 4339/4885
US-20040092628-A1 Substituted 5-aryl-2-(2-hydroxyphenyl)-2h-benzotriazole UV absorbers, compositions stabilized therewith and process for preparatiion thereof AHR, PAH, CCNL2 CNR2 1562/4885CNR1 1751/4885NPC1 4252/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.